Vira Health, a London, UK-based provider of a menopause app called Stella, raised $12m in funding.
The round was led by Octopus Ventures, with participation from Optum Ventures and existing investors. The latest financing builds on a previous $2m funding round that drew investment from LocalGlobe, MMC, Amino Collective, among others.
The company intends to use the funds to grow the app in the US market, conduct clinical trials and add medication and telemedicine.
Founded in 2020 by Andrea Berchowitz, co-founder & chief executive officer, and Dr. Rebecca Love, co-founder, Vira Health provides Stella, a digital therapy app that supports women by offering personalised menopause treatment plans based on their specific symptoms. Stella combines complex guidance around lifestyle and behaviour change into weekly lessons. It offers the ability to interact with trained experts and a range of additional resources, including guided meditations, educational materials, exercises, recipes, and online classes.
In addition to the treatment plans, the platform has articles, recipes, meditations, exercise suggestions and access to virtual events such as yoga classes or Q&A with a gynaecologist. It is now available on iOs in the UK, Ireland and the US as a subscription (£70/year), and through the US-based global benefits platform, BenefitHub.
FinSMEs
16/03/2022